| 摘要 |
The invention relates to the compounds of formula I or its pharmaceutical acceptable salts, as well as polymorphs, solvates, enantiomers, stereoisomers and hydrates thereof. The pharmaceutical compositions comprising an effective amount of compounds of formula I, and methods for the treatment of neurologic diseases may be formulated for oral, buccal, rectal, topical, transdermal, transmucosal, intravenous, parenteral administration, syrup, or injection. Such compositions may be used to treatment of depression, Alzheimer's disease, multiple sclerosis, Batten disease, multiple sclerosis, Parkinson's disease (PD) and restless legs syndrome (RLS). |
| 主权项 |
1. A compound of Formula I: or a pharmaceutically acceptable salt, hydrate, polymorph, solvate, prodrug, enantiomer, or stereoisomer thereof, wherein: R1 represents —OH, —CH3, —F, -D, —OD, —NH2, —H, CD3CO—, Acetyl, —Cl, R2 represents —CH3CO—, acetyl, D, H, CH3CO—, acetyl, D, H, R3 represents a is 2, 3 or 7; each b is independently 3, 5 or 6; e is 1, 2 or 6; and c and d are each independently H, D, —OH, —OD, C1-C6-alkyl, —NH2 or —COCH3. |
